note
usd million
usd million
profit for the year
1846
3 534
depreciation and amortisation
720
822
impairment of non-current assets
370
267
net foreign exchange loss
111
33
loss on disposal of property plant and equipment
23
5
share of profits of associates and joint ventures
-1553
-1 802
gain on partial disposal of investment in associate
−
-492
income tax expense
607
604
write-down of inventories to net realisable value
172
24
impairment of trade and other receivables
169
65
provision for legal claims
10
10
change in fair value of derivative financial instruments
191
352
revaluation of financial assets
-31
47
operating profit before changes in working capital
3470
4 091
increase in inventories
-1098
-1 373
increase in trade and other receivables and advances paid
-418
-455
-decrease/increase in trade and other payables and
advances received
-783
434
cash flows from operations before income tax
1171
2 697
income taxes paid
-599
-529
cash flows from operating activities
572
2 168
the consolidated statement of cash flows is to be read in conjunction with the notes to and forming part of
the consolidated financial statements set out on pages 15 to 84
consolidated statement of cash flows
for the year ended 31 december 2022 -continued
year ended 31 december
2022
2 021
note
usd million
usd million
proceeds from disposal of property plant and equipment
8
20
acquisition of property plant and equipment
-1674
-1 485
acquisition of intangible assets
-37
-28
cash paid for investment in equity securities measured at
fair value through profit and loss
-113
-291
cash received from other investments
111
39
dividends from associates and joint ventures
1639
620
dividends from financial assets
34
34
proceeds from partial disposal of associate
−
1 421
contribution to associates and joint ventures
-8
-9
cash outflow from disposal of subsidiary
-16
−
prepayment for and acquisition of subsidiaries
−
-99
change in restricted cash
-1
−
cash flows from investing activities
47
285
proceeds from borrowings
9129
2 881
repayment of borrowings
-7007
-4 474
acquisition of non-controlling interest
-14
-44
restructuring fees
-21
-36
settlement of derivative financial instruments
-229
-315
dividends to non-controlling shareholders
-129
−
cash flows from / -used in financing activities
742
-2 691
net increase/-decrease in cash and cash equivalents
1361
-238
cash and cash equivalents at beginning of the year
excluding restricted cash
2328
2 549
effect of exchange rate changes on cash and cash equivalents
-215
17
cash and cash equivalents at end of the year
excluding restricted cash
3474
2 328